The time to move to rapid #SARSCoV2 testing is long overdue. It's about switching from diagnosing *infections* to determining whether someone is *infectious*
In minutes, not days. Anywhere. Cheap.
My table here summarizes the differences and why this should be the #1 US priority
In order to get this done, we need a reboot at @US_FDA, which currently requires rapid tests to perform like PCR tests.

That's wrong. This is a new diagnostic category for the *infectious* endpoint, requiring new standards and prospective validation.
The @US_FDA just came around today (yes, a new template, a coincidence with the prior post). Great to see a sign of progress
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-posts-new-template-home-and-over-counter-diagnostic-tests-use-non via @nataliexdean @DanLarremore
You can follow @EricTopol.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:
Those who think consciousness raising & movement building are disconnected, or even a distraction from electoral politics have not paid attention to the history of social change.In this thread, we
Read more
The 2020s will be known as the Remote Work decadeA few predictions of what is likely to emerge[ a thread ] Third Space: Office and Working from Home will
Read more
1/29: Have you ever had a concept explained to you that helps frame complex issues you’ve been wrestling with and opens your eyes to new possibilities? A concept that I
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.